PATENT CLAIM ANALYSIS

Application Number: 16160869
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["424", "234100"]

Abstract:
Compositions consisting of bioactive molecules derived from the microbiota of a mammal are provided herein. When administered orally with a colonic delivery system, the compositions are useful for the prophylaxis and treatment of diseases, in particular inflammatory, autoimmune and infectious diseases. The compositions comprise combinations of small molecules and bacterial antigens formulated in colonic delivery systems. Use of the compositions results in any or all of: induction of immune tolerance; strengthening of the gut mucosal barrier integrity; reduction of inflammation; and amelioration of a disease state caused by inflammation, an autoimmune reaction or an infectious agent.

Claim (Index 8):
A composition having an effect of inducing tolerance, strengthening gut barrier integrity, and reducing inflammation, the composition comprising butyrate and flagellin.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 97.0
- Lexical Diversity: 1.58824
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14903377', '15680629', '14362097', '16117054', '14955630']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6797198756923333
- 35 USC 102 Novelty (BERT): 0.5611412453423807
- Combined Prediction Score: 0.667862012657338
- Mean Citation Score: 331.7430700000001
- Max Citation Score: 478.7297400000001
- Similarity Product: 286.7993084359253

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test